They have a deal with National Green Biomed as well, which is a "late-stage applicant" for a license.
The deals are lining up and the stock is getting cheap at these levels, considering they raised $10.5 million here. These funders cant make money if the stock dont rise and they are big enough whales to keep it from falling much more.
We are very early to this story, its only been public for a month.
My messages contain many opinions. Please do your own research and validation.